Author

Julian Swatler

Instytut Biologii Doświadczalnej im. Marcelego NenckiegoORCID 0000-0001-8710-2808Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

Adrià-Jaume RouraiD· 1 shared Aleksandra Ellert‐MiklaszewskaiD· 1 shared Aleksandra OksiejukiD· 1 shared Antigoni ManousopoulouiD· 1 shared Bartłomiej GielniewskiiD· 1 shared Bozena KaminskaiD· 1 shared Christopher Young· 1 shared Cory WhiteiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrià-Jaume RouraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintApr 24, 2025

Dystrophin Dp71 is essential for the development and function of macrophages

Natalia Chira, Julian Swatler, Antigoni Manousopoulou…·Dariusz C. Górecki

This study shows that Dp71 dystrophin is essential for macrophage development and function, as its absence disrupts migration, phagocytosis, and inflammasome activity in mouse macrophages.

DOI 10.1101/2025.04.24.650386

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 6, 2024

Integrin blocking peptide reverses immunosuppression in experimental gliomas and improves anti-PD-1 therapy outcome

Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak…·Bozena Kaminska

This study shows that an integrin-blocking peptide enhances anti-PD-1 therapy in gliomas by reversing immunosuppression and restoring an inflammatory tumor microenvironment.

2 citations

mousehuman

𝕏 PostBluesky